ArticleCell death & disease2025

eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment.

Didem Karakas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.